Publication | Closed Access

Tailored immunotherapy approach with nivolumab with or without nivolumab plus ipilimumab as immunotherapeutic boost in patients with metastatic renal cell carcinoma (TITAN-RCC): a multicentre, single-arm, phase 2 trial

UrologyImmunotherapeutic BoostGenitourinary CancerMedicineImmunologyImmune Checkpoint InhibitorImmunotherapeuticsImmunotherapy ApproachCancer TreatmentImmunotherapyOncology